CPME signs joint letter from civil society calling for scope and integrity of the AI Act to be preserved
CPME signed the letter together with a broad coalition consumers, hospitals and healthcare services, conformity assessment bodies, and academia to raise concerns about the weakening of the EU's AI Act.
Download joint letter
The joint letter to the European Commission, Cypriot Presidency of the Council of the EU and Members of the European Parliament raises concerns that high-risk medical devices and in vitro medical devices would be removed from the scope of the AI Act, among concerns from numerous other sectors.
Ensuring that these systems remain clearly covered by the AI Act’s governance framework is essential to maintain patient safety and public trust in digital health technologies.
- Read our proposed amendments
- Read our joint letter with HOPE (European Hospital and Healthcare Federation)
- Read our recent press release